Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment

QinChen Xu1, Xiaoyan Liu1, Ghazal Mohseni1

  • 1Department of Clinical Laboratory, The Second Hospital of Shandong University, 247 Beiyuan Street, 250033, Jinan, Shandong, China.

Insights

Nicotinamide adenine dinucleotide (NAD) pathway molecules impact cancer immunity by altering the tumor immune microenvironment (TIME). Targeting these pathways with novel drugs and combination therapies offers promising anticancer strategies.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Nicotinamide adenine dinucleotide (NAD) is central to cellular energy metabolism.
  • Key molecules like NAMPT, Sirtuins, PARP, and CD38 regulate cellular functions and disease development.
  • These NAD pathway molecules influence tumor immunity by modulating the tumor immune microenvironment (TIME).

Purpose of the Study:

  • To review the mechanisms of NAD pathway molecules in tumor immunity.
  • To summarize advances in drug research and combination therapies targeting these molecules.
  • To discuss new technology-based therapies for overcoming challenges like side effects and drug resistance.

Main Methods:

  • Literature review of studies on NAD pathway molecules and cancer immunity.
  • Analysis of current drug development and clinical applications.
  • Exploration of novel therapeutic strategies and technologies.

Main Results:

  • NAD pathway molecules regulate cell energy metabolism, cytokine release, and neoantigen expression.
  • These molecules significantly impact the tumor immune microenvironment (TIME), influencing anticancer effects.
  • Targeted drugs show potential but face challenges like side effects and resistance.

Conclusions:

  • NAD pathway modulation is a promising strategy for cancer immunotherapy.
  • Advancements in drug discovery, combination therapies, and new technologies are crucial for improving efficacy.
  • Further research is needed to optimize therapeutic interventions targeting the NAD pathway in cancer.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
650
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K